NCT04010851

Brief Summary

ADHD is associated with a substantial burden on families, and systems pertaining to health, social care, and criminal justice, and there is a need for more knowledge of the effects of non-pharmacological interventions. Educational and parental activation interventions may improve ADHD symptoms, and may enhance parent activation. Although the results of these studies are promising, few interventions have been carried out in collaboration with user representatives, which is required by Norwegian legislation. As such, there is a need for clinical studies that document the effects of educational group interventions based on user involvement that seeks to improve parental activation. Furthermore, it is not clear which type of educational intervention that should be offered, and which aspects of parenting behaviour to focus on. There is a lack of studies investigating whether adding an intervention designed specifically for families of children with ADHD will be more effective than treatment as usual (TAU). The purpose of the present study is to determine the feasibility and expected size of a substantive randomized controlled trial comparing an ADHD peer co-led educational programme added to TAU.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2022

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 8, 2019

Completed
2.6 years until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

February 14, 2022

Status Verified

January 1, 2022

Enrollment Period

1.3 years

First QC Date

June 28, 2019

Last Update Submit

January 29, 2022

Conditions

Keywords

Parental activationPeer co-led education

Outcome Measures

Primary Outcomes (3)

  • Feasibility of recruitment

    Feasibility of recruitment will be assessed by determining the recruitment rate, by monitoring patient screening and subsequent agreement to participate.

    Over a two year study period

  • Satisfaction with the intervention

    Parent satisfaction will be measured by means of the client satisfaction Questionnaire, CSQ-3 as it applies to the group-based educational programme. The scale comprises three items measured on a scale from 1 (not satisfied) to 4 (very satisfied).

    From baseline to 12- and 52-weeks follow-up

  • Parental activation

    Parental activation will be measure with the P-PAM-13. The 13-items P-PAM has four possible response options ranging from (1) strongly disagree, to (4) strongly agree, and an additional 'not applicable' option.

    From baseline to 12- and 52-weeks follow-up

Secondary Outcomes (8)

  • Parental well-being

    From baseline to 12- and 52-weeks follow-up

  • Parental quality of life

    From baseline to 12- and 52-weeks follow-up

  • Shared decision making

    From baseline to 12- and 52-weeks follow-up

  • Parental involvement in treatment decision

    From baseline to 12- and 52-weeks follow-up

  • Beliefs about medicines

    From baseline to 12- and 52-weeks follow-up

  • +3 more secondary outcomes

Other Outcomes (1)

  • Participation in treatment

    From baseline to 12- and 54-weeks follow-up.

Study Arms (2)

Peer co-led educational group

EXPERIMENTAL

The intervention delivered in a group format is added to treatment as usual. After the parents participate in the one day-intervention, they can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence.

Behavioral: Peer co-led educational group

Control group

OTHER

The control goup will receive treatment as usual.

Behavioral: Comparator treatment as usual

Interventions

The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.

Peer co-led educational group

Control group will receive treatment as usual, including different treatment options that can help alleviate the symptoms of ADHD and arm families with the tools needed to better handle problem behaviors when they arise. These interventions include: medication, psychotherapy, or a combination of these two approaches.

Control group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Parents of children aged 6 - 12 with a formal diagnosis of ADHD, following a standardised assessment.

You may not qualify if:

  • Participants already taking part in research on a parenting intervention will also be ineligible to participate.
  • Families attending other parenting groups

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Mundal I, Grawe RW, Hafstad H, De Las Cuevas C, Lara-Cabrera ML. Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol. BMJ Open. 2020 Dec 2;10(12):e039852. doi: 10.1136/bmjopen-2020-039852.

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Ingunn P. Mundal, PhD

    Molde University College

    PRINCIPAL INVESTIGATOR
  • Mariela Loreto Lara Cabrera, PhD

    St Olavs Hospital, Department of research and development AFFU, and NTNU

    PRINCIPAL INVESTIGATOR
  • Rolf W. Gråwe, Phd prof

    Norwegian University of Science and Technology

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2019

First Posted

July 8, 2019

Study Start

March 1, 2022

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

February 14, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

We anticipate that anonymised trial data may be shared with other researchers to enable international prospective meta-analyses.